Ask AI
Tanya Gupta

Tanya Gupta, MD

Medical Oncologist
Palo Alto Medical Foundation
Palo Alto, California

Explore Activities by Tanya Gupta

Title
Format
Credit Type
Credits
Closing the Age Gap in HR+/HER2- MBC: A Guide for Improving Care of Older Patients

Content Format:

PDF

Credit Type:

--

Credits:

--
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Strategies for Managing AEs and Promoting Adherence to Adjuvant CDK4/6 Inhibitors in Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Selecting Adjuvant Therapy for Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Immune Checkpoint Inhibitor Therapy for HER2-Negative Early-Stage Breast Cancer

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Integrating Adjuvant CDK4/6 Inhibitors Into Care of Patients With HR-Positive/HER2-Negative Early-Stage Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Insights Into How Pathologists Can Guide Clinical Decision-making for HER2-Altered Solid Tumors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Addressing Key Questions: Expert Insights to Guide Pathologist-Informed Clinical Decisions in HER2-Expressing or Amplified Solid Tumors

Content Format:

Video

Credit Type:

ABIM MOC | ABPath MOC | AMA

Credits:

1.00
Current Challenges With Individualizing Therapy for HER2-Negative Early-Stage Breast Cancer

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Applying HER2 Testing Results to Treatment Decisions for Patients With Solid Tumors

Content Format:

Slideset

Credit Type:

--

Credits:

--
(Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--